The antioxidative and anti-proliferative potential of non-edible organs of the pomegranate fruit and tree

LWT

Volumn 58, Issue 2, 2014, Pages 571-577

  Orgil, Ola ^a,b   Schwartz, Elinor ^a   Baruch, Lior ^a   Matityahu, Ifat ^a   Mahajna, Jamal ^a,b   Amir, Rachel ^a,b  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b TEL HAI COLLEGE   (Israel)

Author keywords

Antioxidant activity; Cancer cell lines; Ellagitanins; Non edible tissues; Pomegranate

Indexed keywords

ANTIOXIDANTS; CANCER CELLS; CELL CULTURE; CELLS; DISEASES; FORESTRY; HISTOLOGY; PLANTS (BOTANY); TISSUE;

ANTIOXIDANT ACTIVITIES; ANTIOXIDATIVE; CANCER CELL LINES; EDIBLE TISSUE; ELLAGITANINS; NON-EDIBLE TISSUE; POMEGRANATE; PROPERTY; PUNICALAGIN; TOTAL PHENOL CONTENTS;

FRUITS;

ANTIOXIDANTS; FORESTRY; FRUITS; TISSUE CULTURE;

LYTHRACEAE; PUNICA GRANATUM;

EID: 84901285121     PISSN: 00236438     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lwt.2014.03.030     Document Type: Article

References (49)

1. Adams L.S., Seeram N.P., Aggarwal B.B., Takada Y., Sand D., Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. Journal of Agricultural and Food Chemistry 2006, 54(3):980-985. 10.1021/jf052005r.
2. Adams S., Seeram P., Aggarwal B., Takada Y., Sand D., Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. Journal of Agricultural and Food Chemistry 2006, 54(3):980-985.
3. Adams L.S., Zhang Y., Seeram N.P., Heber D., Chen S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Preventation Ressreach (Phila) 2010, 3(1):108-113. 10.1158/1940-6207.CAPR-08-0225.
4. Adhami V.M., Khan N., Mukhtar H. Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutrtion and Cancer 2009, 61(6):811-815. doi: 916759049 10.1080/01635580903285064.
5. Albrecht M., Jiang W., Kumi-Diaka J., Lansky E.P., Gommersall L.M., Patel A., et al. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. Journal of Medicinal Food 2004, 7(3):274-283. 10.1089/1096620041938704.
6. Aqil F., Munagala R., Vadhanam M.V., Kausar H., Jeyabalan J., Schultz D.J., et al. Anti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate husk. Food Research International 2012, 49(1):345-353. 10.1016/j.foodres.2012.07.059.
7. Aviram M., Dornfeld L., Kaplan M., Coleman R., Gaitini D., Nitecki S., et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs under Experimental and Clinical Research 2002, 28(2-3):49-62.
8. Aviram M., Rosenblat M., Gaitini D., Nitecki S., Hoffman A., Dornfeld L., et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clinical Nutrition 2004, 23(3):423-433. [pii]. 10.1016/j.clnu.2003.10.002S0261561 403002139.
9. Aviram M., Volkova N., Coleman R., Dreher M., Reddy M.K., Ferreira D., et al. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: Studies in vivo in atherosclerotic apolipoprotein E-deficient (E-o) mice and in vitro in cultured macrophages and upoproteins. Journal of Agricultural and Food Chemistry 2008, 56(3):1148-1157. gil. 10.1021/ jf071811q.
10. Bekir J., Mars M., Souchard J.P., Bouajila J. Assessment of antioxidant, anti-inflammatory, anti-cholinesterase and cytotoxic activities of pomegranate (Punica granatum) leaves. Food and Chemical Toxicology: an international journal published for the British Industrial Biological Research Association 2013, 55:470-475. 10.1016/j.fct.2013.01.036.
11. Ben Nasr C., Ayed N., Metche M. Quantitative determination of the polyphenolic content of pomegranate peel. Zeitschrift für Le0bensmittel-Untersuchung und -Forschung 1996, 203(4):374-378.
12. Bialonska D., Kasimsetty S.G., Khan S.I., Ferreira D. Urolithins, intestinal microbial metabolites of pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay. Journal of Agricultural and Food Chemistry 2009, 57(21):10181-10186.
13. Cerda B., Ceron J.J., Tomas-Barberan F.A., Espin J.C. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. Journal of Agricultural and Food Chemistry 2003, 51(11):3493-3501. 10.1021/jf020842c.
14. Dikmen M., Ozturk N., Ozturk Y. The antioxidant potency of Punica granatum L. fruit peel reduces cell proliferation and induces apoptosis on breast cancer. Journal of Medicinal Food 2011, 14(12):1638-1646. 10.1089/jmf.2011.0062.
15. Fotakis G., Timbrell J.A. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006, 160(2):171-177. 10.1016/j.toxlet.2005. 07.001.
16. Gil M.I., Tomas-Barberan F.A., Hess-Pierce B., Holcroft D.M., Kader A.A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. Journal of Agricultural and Food Chemistry 2000, 48(10):4581-4589. doi: gl[pii].
17. Glazer I., Masaphy S., Marciano P., Bar-Ilan I., Holland D., Kerem Z., et al. Partial identification of bioactive compounds having antifungal activities from Punica granatum peel extracts. Journal of Agricultural and Food Chemistry 2012, 60(19):4841-4848. 10.1021/jf300330y.
18. Heber D., Seeram N.P., Wyatt H., Henning S.M., Zhang Y., Ogden L.G., et al. Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size. Journal of Agricultural and Food Chemistry 2007, 55(24):10050-10054. 10.1021/jf071689v.
19. Holland D., Hatib K., Bar-Ya'akov I. Pomegranate: botany, horticulture, breeding. Horticultural reviews 2009, 127-191. John Wiley & Sons, Inc.
20. Huang T.H., Yang Q., Harada M., Li G.Q., Yamahara J., Roufogalis B.D., et al. Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. Journal of Cardiovascular Pharmacology 2005, 46(6):856-862. doi: 00005344-200512000-00021 [pii].
21. Ismail T., Sestili P., Akhtar S. Pomegranate peel and fruit extracts: a review of potential anti-inflammatory and anti-infective effects. Journal of Ethnopharmacology 2012, 143(2):397-405. 10.1016/j.jep.2012.07.004.
22. Jayaprakasha G., Jena B., Negi P. Antimicrobial activities of pomegranate. Pomegranates: Ancient roots to modern medicine 2006, 167-183. CRC Press. N.P. Seeram, R.N. Schulman, D. Heber (Eds.).
23. Kim N.D., Mehta R., Yu W., Neeman I., Livney T., Amichay A., et al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Ressearch and Treatment 2002, 71(3):203-217.
24. Langley P. Why a pomegranate?. British Medical Journal 2000, 321(7269):1153-1154.
25. Lansky E.P., Harrison G., Froom P., Jiang W.G. Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Investigational New Drugs 2005, 23(2):121-122. 10.1007/s10637-005-5856-7.
26. Lansky E.P., Newman R.A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. Journal of Ethnopharmacoogy 2007, 109(2):177-206. doi: S0378-8741(06)00457-0 [pii]10. 1016/j.jep.2006.09.006.
27. Larrosa M., Tomas-Barberan F.A., Espin J.C. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. The Journal of Nutritional Biochemistry 2006, 17(9):611-625. doi: S0955-2863(05)00241-X [pii] 10.1016/j.jnutbio.2005.09.004.
28. Manasathien J., Indrapichate K., Intarapichet O.K. Antioxidant activity and bioefficacy of pomegranate Punica granatum Linn. peel and seed extracts. Global Journal of Pharmacology 2012, 6(2):131-141. 10.5829/idosi.gjp.2012.6.2.64226.
29. Mena P., Garcia-Viguera C., Navarro-Rico J., Moreno D.A., Bartual J., Saura D., et al. Phytochemical characterisation for industrial use of pomegranate (Punica granatum L.) cultivars grown in Spain. Journal of the Science of Food and Agriculture 2011, 91(10):1893-1906. 10.1002/jsfa.4411.
30. Motaal A.A., Shaker S. Anticancer and antioxidant activities of standardized whole fruit, pulp, and peel extracts of Egyptian pomegranate. The Open Conference Proceedings Journal 2011, 2:41-45.
31. Neurath A.R., Strick N., Li Y.Y., Debnath A.K. Punica granatum (pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide. Annals of the New York Academy of Sciences 2005, 1056:311-327. doi: 1056/1/311 [pii]10.1196/annals.1352.015.
32. Ono N.N., Bandaranayake P.C., Tian L. Establishment of pomegranate (Punica granatum) hairy root cultures for genetic interrogation of the hydrolyzable tannin biosynthetic pathway. Planta 2012, 236(3):931-941. 10.1007/s00425-012-1706-y.
33. Orak H.H., Yagar H., Isbilir S.S. Comparison of antioxidant activities of juice, peel, and seed of pomegranate (Punica granatum L.) and inter-relationships with total phenolic, tannin, anthocyanin, and flavonoid contents. Food Science and Biotechnology 2012, 21(2):373-387. 10.1007/s10068-012-0049-6.
34. Panichayupakarananta P., Issuriya A., Sirikatitham A., Wang W. Antioxidant assay-guided purification and LC determination of ellagic acid in pomegranate peel. Journal of Chromatographic Science 2010, 48(6):456-459.
35. Petrova R.D., Mahajna J., Wasser S.P., Ruimi N., Denchev C.M., Sussan S., et al. Marasmius oreades substances block NF-kappaB activity through interference with IKK activation pathway. Molecular Biology Reports 2009, 36(4):737-744. 10.1007/s11033-008-9237-0.
36. Quideau S., Deffieux D., Douat-Casassus C., Pouysegu L. Plant polyphenols: chemical properties, biological activities, and synthesis. Angewandte Chemie International Edition in English 2011, 50(3):586-621. 10.1002/anie.201000044.
37. Rosenblat M., Hayek T., Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 2006, 187(2):363-371. doi: S0021-9150(05)00603-9 [pii]10.1016/j.atherosclerosis.2005.09.006.
38. Sartippour M.R., Seeram N.P., Rao J.Y., Moro A., Harris D.M., Henning S.M., et al. Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. International Journal of Oncology 2008, 32(2):475-480.
39. Schwartz E., Tzulker R., Glazer I., Bar-Ya'akov I., Tripler E., Wiesman Z., et al. Environmental conditions affect the color, taste and antioxidant capacity of 11 pomegranate accessions' fruits. Journal of Agricultural and Food Chemistry 2009, 57(9):9197-9209. 10.1021/jf901466c.
40. Seeram N.P., Adams L.S., Henning S.M., Niu Y., Zhang Y., Nair M.G., et al. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. The Journal of Nutritional Biochemistry 2005, 16(6):360-367. doi: S0955-2863(05)00019-7 [pii]10.1016/j.jnutbio.2005.01.006.
41. Seeram N., Lee R., Hardy M., Heber D. Rapid large scale purification of ellagitannins from pomegranate husk, a by-product of the commercial juice industry. Separation and Purification Technology 2005, 41(1):49-55.
42. Seeram N.P., Zhang Y., Reed J.D., Krueger C.G., Vaya J. Pomegranate phytochemicals. Pomegranates ancient roots to modern medicine 2006, 3-29. CRC Press. N.P. Seeram, R.N. Schulman, D. Heber (Eds.).
43. Shabtay A., Eitam H., Tadmor Y., Orlov A., Meir A., Weinberg P., et al. Nutritive and antioxidative potential of fresh and stored pomegranate industrial byproduct as a novel beef cattle feed. Journal of the Science of Food and Agriculture 2008, 56(21):10063-10070. 10.1021/jf8016095.
44. Shishir S., Adams S., Bhatt I., Aggarwal B. Anticancer potenitial of pomegranate. Pomegranates ancient roots to modern medicine 2006, 63-90. CRC Press. N.P. Seeram, R.N. Schulman, D. Heber (Eds.).
45. Singh R.P., Chidambara Murthy K.N., Jayaprakasha G.K. Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models. Journal of the Science of Food and Agriculture 2002, 50(1):81-86.
46. Toi M., Bando H., Ramachandran C., Melnick S.J., Imai A., Fife R.S., et al. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 2003, 6(2):121-128. doi: 10.1023/B: AGEN.0000011802.81320.e45255609 [pii].
47. Tzulker R., Glazer I., Bar-Ilan I., Holland D., Aviram M., Amir R. Antioxidant activity, polyphenol content, and related compounds in different fruit juices and homogenates prepared from 29 different pomegranate accessions. Journal of the Science of Food and Agriculture 2007, 55(23):9559-9570. 10.1021/jf071413n.
48. Wang R., Ding Y., Liu R., Xiang L., Du L.J. Pomegranate: constituents, bioactivities and pharmacokinetics. Pomegranate. Fruit, vegetable and cereal science and biotechnology 2010, Vol. 4:77-87. Special Issue 2. R. Chandra (Ed.).
49. Yoshida T., Amakura Y., Yoshimura M. Structural features and biological properties of ellagitannins in some plant families of the order myrtales. International Journal of Molecular Science 2010, 11(1):79-106. 10.3390/ijms11010079.